Skip to content

Prabhav of apamarga kshara and jatyadi tail pichu in garbhashaygata Disease

To evaluate the efficacy of Apamarga Kshara and Jatyadi Taila Pichu in Cervical Erosion - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/07/091624
Enrollment
60
Registered
2025-07-24
Start date
Unknown
Completion date
Unknown
Last updated
2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N86- Erosion and ectropion of cervix uteri

Interventions

None listed

Sponsors

Dr Saloni Devi
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Only married women of different age group & parity. Patients must having erosion on their cervix.

Exclusion criteria

Exclusion criteria: Unmarried 2. Patients suffering from any specific organic lesions such as Tuberculosis, acute or chronic respiratory diseases, cardiac diseases, renal diseases, Diabetes mellitus, Hypertension etc. 3. Women with Carcinoma of cervix, benign or malignant growth of reproductive tract, any degree of Genital prolapse, PCOD, hypoplastic uterus, any congenital abnormality of genital tract. 4. Severe anaemic patients (Hb less than 7gm%). 5. Patients having their VDRL reactive. 6. Patients with cervical Pap smear showing either CIN or papilloma virus infection or invasive malignancy. 7. Patients with pregnancy history of recent delivery of three month or taking OCPs.

Design outcomes

Primary

MeasureTime frame
Finally the treatment will be assessed on the basis of following criteria of improvement of symptoms and sign i.e. erosion, which will based on Ayurveda and Modern science. (1) Improvement in the findings. (2) Reduction in the discharge. Timepoint: 4 weeks

Secondary

MeasureTime frame
Routine Examinations a. Blood : Hb% (In gram % by Shahli s method) TLC (By Neubar s method) DLC (By Neubar s method) ESR (By Westergren method) FBS Blood urea VDRL b. Urine : Routine and Microscopic. Specific examination These were to know vaginal infection, cytology and to exclude malignancy. Timepoint: 8 WEEKS

Countries

India

Contacts

Public ContactDr Saloni Devi

S G M P G Ayurvedic College and Hospital

drshyamlal80@gmail.com9415970999

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026